Lynne M. Postovit

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

The Emerging Role of mTOR in Shaping the Cancer Cell Secretome and Plasticity.

The Emerging Role of mTOR in Shaping the Cancer Cell Secretome and Plasticity.

Journal: Molecular and cellular biology
Published: July 14, 2026

Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.

Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.

Journal: Gynecologic oncology
Published: March 28, 2024

Tandem SERS and MS/MS Profiling of Plasma Extracellular Vesicles for Early Ovarian Cancer Biomarker Discovery.

Tandem SERS and MS/MS Profiling of Plasma Extracellular Vesicles for Early Ovarian Cancer Biomarker Discovery.

Journal: ACS sensors
Published: January 12, 2024

Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition.

Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition.

Journal: Journal of translational medicine
Published: November 13, 2023

Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.

Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.

Journal: Gynecologic oncology
Published: June 08, 2023

N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence.

N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence.

Journal: Cancers
Published: February 10, 2021

SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.

SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.

Journal: The journal of pathology. Clinical research
Published: August 30, 2020

Genome profiles of pathologist-defined cell clusters by multiregional LCM and G&T-seq in one triple-negative breast cancer patient.

Genome profiles of pathologist-defined cell clusters by multiregional LCM and G&T-seq in one triple-negative breast cancer patient.

Journal: Cell reports. Medicine
Published: July 15, 2020

Targeting N-myristoylation for therapy of B-cell lymphomas.

Targeting N-myristoylation for therapy of B-cell lymphomas.

Journal: Nature communications
Published: November 18, 2019

Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial.

Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial.

Journal: BMJ open
Published: September 19, 2019

Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma.

Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma.

Journal: Frontiers in psychiatry
Published: June 07, 2019

Prediction and Understanding of Resilience in Albertan Families: Longitudinal Study of Disaster Responses (PURLS) - Protocol.

Prediction and Understanding of Resilience in Albertan Families: Longitudinal Study of Disaster Responses (PURLS) - Protocol.

Journal: Frontiers in psychiatry
Published: May 07, 2019
Showing 1-12 of 25

Last Updated: 09/26/2026